Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Current Assets | Inventory | Current Liabilities | Quick Ratio |
---|---|---|---|---|
6/30/2025 | $ 409.08M | $ 0 | $ 44.64M | 9.16 |
3/31/2025 | $ 454.48M | $ 0 | $ 49.78M | 9.13 |
12/31/2024 | $ 531.3M | $ 0 | $ 71.61M | 7.42 |
9/30/2024 | $ 604.99M | $ 0 | $ 60.41M | 10.02 |
6/30/2024 | $ 686.81M | $ 0 | $ 69.04M | 9.95 |
3/31/2024 | $ 755.44M | $ 0 | $ 61.8M | 12.22 |
12/31/2023 | $ 869.35M | $ 0 | $ 82.75M | 10.51 |
9/30/2023 | $ 933.27M | $ 0 | $ 133M | 7.02 |
6/30/2023 | $ 1.06B | $ 0 | $ 96.81M | 10.99 |
3/31/2023 | $ 1.2B | $ 0 | $ 84.69M | 14.21 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(AssetsC - Inventory) / LiabilitesC
(=) Quick Ratio
Quick Ratio for SAGE THERAPEUTICS INC is calculated as follows: (AssetsC [ $ 698.88M ] - Inventory [ $ 0 ]) / LiabilitesC [ $ 59.66M ]
(=) Quick Ratio [ 11.71 ]
Minimum
Sep 30, 2023
Maximum
Mar 31, 2021
Average
Median
filtered constituents | 3.12K |
---|---|
min | -0.73 |
max | 5.45 |
average | 1.55 |
median | 1.23 |
std | 1.17 |